Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Long-Term Debt Repayments (2020 - 2024)

Agilon Health (AGL) has disclosed Long-Term Debt Repayments for 5 consecutive years, with $1.2 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Long-Term Debt Repayments changed 0.0% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Jun 2025, down 75.0%, and an annual FY2024 reading of $3.8 million, down 25.0% over the prior year.
  • Long-Term Debt Repayments was $1.2 million for Q3 2024 at Agilon Health, roughly flat from $1.2 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $68.6 million in Q1 2021 and bottomed at -$1000.0 in Q3 2021.
  • Average Long-Term Debt Repayments over 5 years is $7.2 million, with a median of $1.2 million recorded in 2022.
  • The sharpest move saw Long-Term Debt Repayments tumbled 100.13% in 2021, then surged 125100.0% in 2022.
  • Year by year, Long-Term Debt Repayments stood at $760000.0 in 2020, then skyrocketed by 64.74% to $1.3 million in 2021, then decreased by 0.16% to $1.2 million in 2022, then changed by 0.0% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024.
  • Business Quant data shows Long-Term Debt Repayments for AGL at $1.2 million in Q3 2024, $1.2 million in Q2 2024, and $1.2 million in Q1 2024.